
Keywords: Anaphylaxis; β-blocker; angiotensin-converting enzyme inhibitor; cofactor; mast cells; cardiovascular medication; ACE; Angiotensin-converting enzyme; BMcMCs; Bone marrow-cultured mast cell; cAMP; Cyclic AMP; LT; Leukotriene; MC; Mast cell; mMCP-1; Mous